Firstnasal monoclonal antibody treatment for COVID-19 published March 8, 2023

[keepontruckin]

https://www.sciencedaily.com/releases/2023/03/230308084337.htm

"Next, we are going to look at studying the use of Foralumab in long COVID, larger studies of multiple sclerosis, and other diseases such as Alzheimer's disease."

Also published today
https://www.sciencedaily.com/releases/2023/03/230308112118.htm March 8, 2023

Potential new therapeutic target for inflammatory diseases such as lupus and sepsis

Scientists have made an important breakthrough in understanding what goes wrong in our bodies during the progression of inflammatory diseases and -- in doing so -- unearthed a potential new therapeutic target. The scientists have found that an enzyme called fumarate hydratase is repressed in macrophages, a frontline inflammatory cell type implicated in a range of diseases including lupus, arthritis, sepsis and COVID-19.

 

[linusbert]

https://www.sciencedaily.com/releases/2023/03/230308084337.htm

"Next, we are going to look at studying the use of Foralumab in long COVID, larger studies of multiple sclerosis, and other diseases such as Alzheimer's disease."

Also published today
https://www.sciencedaily.com/releases/2023/03/230308112118.htm March 8, 2023

Potential new therapeutic target for inflammatory diseases such as lupus and sepsis

Scientists have made an important breakthrough in understanding what goes wrong in our bodies during the progression of inflammatory diseases and -- in doing so -- unearthed a potential new therapeutic target. The scientists have found that an enzyme called fumarate hydratase is repressed in macrophages, a frontline inflammatory cell type implicated in a range of diseases including lupus, arthritis, sepsis and COVID-19.

and costs like 5000 $ per sniff? we all know how it works.

i welcome the approach. but i fear i can't afford it.